InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,242.00
(
1.55%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.02%
)
Bitcoin
63,940.77
(
-0.84%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

remind2

Send PM Follow Ignore
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

remind2

Re: None

Friday, 10/21/2016 12:27:12 AM

Friday, October 21, 2016 12:27:12 AM

Post# of 23979
GOVX: GeoVax posts landmark HIV vaccine news.

While many investors have been waiting for news on the Zika Virus vaccine front, GeoVax updated their HIV vaccine Phase 1 work with some stunning news.

Certainly good news for the global fight against HIV and very strong news for investors.

GeoVax HIV vaccine. Phase 1 news:
http://www.stockhouse.com/news/press-releases/2016/10/20/geovax-hiv-vaccine-clinical-data-presented-at-hivr4p-conference

NOTE: The GOVX news likely will trigger the milestone awards that are pending.
http://www.geovax.com/news-events/entry/2016/08/02/geovax-awarded-nih-contract-for-up-to-7-8-million-to-manufacture-hiv-vaccine-for-advanced-human-clinical-trials.html
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up